Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. - Alharbi AS; Abu-Shraie N; Al Abdulkarim H; Alharbi IH; Averin A; Law AW; Mendes D; Quinn E; Zayed M; Behiry A; Haridy H; Mousa M (Infectious diseases and therapy, 2026)